[Impact of the LACC study. A SFOG survey].

Impact de l’étude LACC. Une enquête de la SFOG.

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
May 2020
Historique:
received: 13 02 2020
accepted: 25 02 2020
pubmed: 5 4 2020
medline: 5 6 2020
entrez: 5 4 2020
Statut: ppublish

Résumé

The LACC (Laparoscopic Approach to Cervical Cancer Trial) study, released in 2018, described oncological findings in favour of open surgery compared to the minimally invasive pathway in the management of early stage cervical cancers. Our aim was to assess the impact of this study on surgical practices in France. Online questionnaire, consisting of 13 questions addressed to gynecology oncology french society (SFOG) surgeons. Forty questionnaires were collected. The median annual number of radical hysterectomy was 5 (0-20). Prior to the study, 92.5 % of cervical cancer patients had radical hysterectomy by minimally invasive surgery. In case of laparoscopy or robot, the uterine manipulator was used in 67.6 % and the colpotomy was performed intra-abdominally (78.4 %). After the LACC study, 60 % changed their practice. Open surgery was favored by 75 % of those who modified their practice. Among those continuing to perform minimally invasive surgeries, the manipulator and the intracorporeal colpotomy were discontinued. One-third of surgeons have changed their surgical practice for endometrial cancer in parallel. The results of the LACC study led to a change in surgical practices with an increase in open surgery and a stop in the use of the uterine manipulator and the laparoscopic/robotic intracorporeal colpotomy in the surgical management of early stage of cervical cancer.

Identifiants

pubmed: 32245607
pii: S0007-4551(20)30150-8
doi: 10.1016/j.bulcan.2020.02.012
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

551-555

Informations de copyright

Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Tristan Gauthier (T)

CHU Limoges, hôpital Mère-Enfant, service de gynécologie-obstétrique, 8, avenue Dominique-Larrey, 87042 Limoges, France. Electronic address: tristan.gauthier@chu-limoges.fr.

Aymeline Lacorre (A)

CHU Limoges, hôpital Mère-Enfant, service de gynécologie-obstétrique, 8, avenue Dominique-Larrey, 87042 Limoges, France.

Camille Sallee (C)

CHU Limoges, hôpital Mère-Enfant, service de gynécologie-obstétrique, 8, avenue Dominique-Larrey, 87042 Limoges, France.

Antoine Tardieu (A)

CHU Limoges, hôpital Mère-Enfant, service de gynécologie-obstétrique, 8, avenue Dominique-Larrey, 87042 Limoges, France.

Frédéric Guyon (F)

Institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France.

François Margueritte (F)

CHU Limoges, hôpital Mère-Enfant, service de gynécologie-obstétrique, 8, avenue Dominique-Larrey, 87042 Limoges, France.

Sébastien Gouy (S)

Département de chirurgie, Gustave Roussy Cancer Campus, 94800 Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH